Latest news
Loading news…
Excision BioTherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Philadelphia, Pennsylvania, United States Founded 2015 11-50 employees For Profit
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
31
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Active products
- 6
- IT spend
- $293K
Company Info
- Founded
- 2015
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 34
- HQ
- Philadelphia, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 0
- Trend (90d)
- -0.7
Key People at Excision BioTherapeutics
Chief Medical Officer
Co-Founder
Interim Chief Business Officer
31
professional contacts at Excision BioTherapeutics
Contact execs at Excision BioTherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Excision BioTherapeutics
Loading news…
FAQs about Excision BioTherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.